Death from bronchial asthma
There is now incontrovertible evidence that there is a progressive and strikingly increased mortality from bronchial asthma in the US. The increase is more dramatic in the older age groups, but younger age groups are not spared. The exact cause or causes of this increased mortality are not known, and it is even possible (although not likely) that the increase is artifactual. This increased death rate is in sharp contrast to the general medical perception that major advances in the management of bronchial asthma have occurred. Perhaps they have, but if so, more patients are dying during this period of advances than were dying before. The most prudent course would be to assume that the excess deaths are iatrogenic in origin and to act accordingly. Even if this assumption is flawed, acting on it would improve the management of patients with bronchial asthma. If it is true that the major purpose of risk-benefit analysis is to improve patient outcome rather than merely analyze risk-benefit balance, then a series of proposals can be generated to grapple with this problem in bronchial asthma.
Enhancement of cardiotoxic effects of beta-adrenergic bronchodilators by aminophylline in experimental animals
Prognosis among patients with out-of-hospital cardiac arrest judged as being caused by deterioration of obstructive pulmonary disease
Deaths from asthma in Italy (1974-1988): is there a relationship with changing pharmacological approaches?
Demographic characteristics of patients experiencing near-fatal and fatal asthma: results of a regional survey of 400 asthma specialists [see comment
Effect of a preprinted form on the management of acute asthma in an accident and emergency department
Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale
Heliox improves pulmonary mechanics in a pediatric porcine model of induced severe bronchospasm and independent lung mechanical ventilation
Evaluation of bone metabolism after the use of an inhaled glucocorticoid (flunisolide) in patients with moderate asthma
Patient, professional, and public education on behavioral aspects of asthma: a review of strategies for change and needed research
Mortality from airways disorders in Alberta, 1927-1987: an expanding epidemic of COPD, but asthma shows little change
Characteristics of allergic sensitization among asthmatic adults older than 55 years: results from the National Health and Nutrition Examination Survey, 2005-2006
The diagnosis of potentially fatal asthma in hospitalized adults. Patient characteristics and increased severity of asthma
Inflammation and bronchial hyperresponsiveness in allergic asthma and chronic obstructive pulmonary disease
Efficacy and safety of a rapid-sequence metaproterenol protocol in the treatment of acute adult asthma
The efficacy and safety of a continuous albuterol protocol for the treatment of acute adult asthma attacks
Halothane, an effective infrequently used drug, in the treatment of pediatric status asthmaticus: a case report
This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.
Allergy and Asthma
Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.